These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11374718)

  • 1. Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic steatorrhea?
    Chung JP; Lee SJ; Park HJ; Lee KS; Chung JB; Lee SI; Kang JK
    Am J Gastroenterol; 2001 May; 96(5):1643-5. PubMed ID: 11374718
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancrelipase for pancreatic disorders: An update.
    Dhanasekaran R; Toskes PP
    Drugs Today (Barc); 2010 Nov; 46(11):855-66. PubMed ID: 21225024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
    Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme-based drugs in pancreatic diseases].
    Shcherbakov PL
    Klin Med (Mosk); 2001; 79(11):71-4. PubMed ID: 11811117
    [No Abstract]   [Full Text] [Related]  

  • 9. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
    Satoi S; Sho M; Yanagimoto H; Yamamoto T; Akahori T; Kinoshita S; Nagai M; Hirooka S; Yamaki S; Nishiwada S; Ryota H; Ikeda N; Nakajima Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Mar; 23(3):167-73. PubMed ID: 26748629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of pancrealipase delayed-release capsules (Creon) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery].
    Vitkomb D; Maleska-Panas E; Lekhman G; Vasil'eva N; Gubergrits N; Karas S; Shen Ia; Sander-Strukmaer S
    Eksp Klin Gastroenterol; 2010; (3):65-70. PubMed ID: 20496792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
    Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
    Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic pancreatitis: comparative assessment of effectiveness of dose-dependent therapy and prophylaxis of recurrence by polyenzyme drugs].
    Butorova LI; Vasil'ev AP; Kozlov IM; Kuz'michev SB; Popova TN; Eletskaia AO; Egorycheva MP; Rassypnova LI
    Eksp Klin Gastroenterol; 2007; (6):96-102. PubMed ID: 18416102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Digestive action of acid-protected lipase in pancreatogenic steatorrhea].
    Brackmann P; Rüther HG
    Fortschr Med; 1984 Nov; 102(44):1143-5. PubMed ID: 6396183
    [No Abstract]   [Full Text] [Related]  

  • 15. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
    Saito T; Nakai Y; Isayama H; Hirano K; Ishigaki K; Hakuta R; Takeda T; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Takahara N; Hamada T; Uchino R; Mizuno S; Mouri D; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
    Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Nagai M; Sho M; Satoi S; Toyokawa H; Akahori T; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kinoshita S; Nishiwada S; Ikeda N; Kwon AH; Nakajima Y
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):186-92. PubMed ID: 23798362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study.
    Saito T; Hirano K; Isayama H; Nakai Y; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Hamada T; Takahara N; Uchino R; Mizuno S; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
    Pancreas; 2017 Mar; 46(3):341-346. PubMed ID: 28099252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Yamazaki S; Takayama T; Higaki T; Moriguchi M; Yoshida N; Miyazaki T; Teshima Y
    J Gastroenterol; 2016 Jan; 51(1):55-62. PubMed ID: 25904096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML; Rumessen JJ
    Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease in pancreatic steatorrhoea by positioned-release enzyme capsules.
    Taylor RH; Mee AS; Misiewicz JJ; Barnardo DE; Polanska N
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1392-3. PubMed ID: 6814569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.